Why Denosumab Obtains a Survival Benefit over Zoledronic Acid in Bone Metastatic Lung Cancer Patients?

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles